APA

Sakamoto T., Ishii Y., Shiba H., Furukawa K., Fujiwara Y., Haruki K., Iwase R., Shirai Y. & Yanaga K. (20170106). Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production. : Anticancer research.

Chicago

Sakamoto Taro, Ishii Yuji, Shiba Hiroaki, Furukawa Kenei, Fujiwara Yuki, Haruki Koichiro, Iwase Ryota, Shirai Yoshihiro and Yanaga Katsuhiko. 20170106. Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production. : Anticancer research.

Harvard

Sakamoto T., Ishii Y., Shiba H., Furukawa K., Fujiwara Y., Haruki K., Iwase R., Shirai Y. and Yanaga K. (20170106). Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production. : Anticancer research.

MLA

Sakamoto Taro, Ishii Yuji, Shiba Hiroaki, Furukawa Kenei, Fujiwara Yuki, Haruki Koichiro, Iwase Ryota, Shirai Yoshihiro and Yanaga Katsuhiko. Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production. : Anticancer research. 20170106.